hERGスクリーニングの世界市場レポート 2024年

hERGスクリーニング市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR12.5％で26億米ドルに成長します。予測期間における成長の背景には、個別化医療の拡大、医薬品開発業務のアウトソーシングの急増、新市場や研究開発の勃興、非心臓安全性評価への注目の高まりなどがあります。この期間に予想される主な動向には、in vitroモデルの進歩、ゲノムおよびプロテオミクスデータの統合、計算機によるアプローチの進歩、小児用医薬品の安全性の重視、データ共有と標準化のための共同研究の増加などがあります。

心臓疾患の患者数の増加が予想されることから、hERGスクリーニング市場の成長が見込まれます。心臓や血管に影響を及ぼす様々な疾患を含む心臓疾患は、深刻な健康リスクをもたらし、不健康なライフスタイル、高齢化、遺伝的素因、糖尿病、メタボリックシンドロームなどの要因に影響されます。hERGスクリーニングは、潜在的な薬剤候補を同定し、心臓の有害事象、特にTdP（Torsade de Pointes）を予防し、最終的に患者の転帰を改善する上で重要な役割を果たしています。2023年5月現在、米国疾病予防管理センターは、米国では20歳以上の成人の20人に1人が心血管疾患に罹患しており、2021年には695,000人が心血管疾患に罹患し、375,476人が死亡したと報告しています。さらに、2022年3月、国家統計局は、英国における2020年の心臓発作関連死は19,440人で、2021年には20,061人に増加すると報告しました。心臓疾患の有病率の増加は、hERGスクリーニング市場の成長を促進する極めて重要な要因です。

hERGスクリーニング市場の主な企業は、医薬品開発プロセスにおける心臓安全性評価を強化するため、GLP認定hERGスクリーニングサービスなどの革新的ソリューションに積極的に注力しています。GLP認定のhERGスクリーニングでは、ICH S7AやICH S7Bなどの規制ガイドラインに準拠した、従来の全細胞パッチクランプ法を用いたヒトエーテル-a-go-go関連遺伝子（hERG）のスクリーニングを行います。これらのガイドラインは、医薬品開発における安全性薬理試験にとって極めて重要です。例えば、2023年8月、英国の製薬会社Metrion Biosciences Ltd.は、GLP認定のhERGスクリーニングサービスを導入しました。このサービスは、低分子治療薬の開発をサポートし、既存の心臓安全性サービスポートフォリオを補完するよう設計されており、第1相臨床試験に入る前に、従来の全細胞パッチクランプ法を用いて潜在的な心臓負債を評価します。また、安全性薬理試験のための規制ガイダンスを提供し、イオンチャンネルターゲットのための高品質な生物学的サービスを提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のhERGスクリーニング市場：タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 遺伝子KCNH2
• 変異KCNH2
• 世界のhERGスクリーニング市場：イオンチャネル別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 電圧ゲート
• リガンドゲート
• 世界のhERGスクリーニング市場：用途別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 抗不整脈薬
• 抗精神病薬
• 抗生物質
• その他の用途

第7章 地域別・国別分析

• 世界のhERGスクリーニング市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 世界のhERGスクリーニング市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• hERGスクリーニング市場：競合情勢
• hERGスクリーニング市場：企業プロファイル
  • Eurofins-Cerep SA.
  • Aviva Biosciences Inc.
  • AstraZeneca Public Limited Company
  • Merck KGaA
  • Charles River Laboratories Inc.

第31章 その他の大手企業と革新的企業

• Abcam Public Limited Company
• Molecular Devices LLC
• Caliper Life Sciences Inc.
• Crprotex Limited
• ChanTest Corporation
• Creative bioarray Inc.
• Cellular Dynamics International Inc.
• Nanion Technologies
• Essen Bioscience
• ABR-Affinity BioReagents Inc.
• ACEA Biosciences Inc.
• Metrion biosciences Inc.
• Aurora Biomed Inc.
• Aureus Sciences
• RedShift BioAnalytics

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

Human Ether-a-go-go-related gene (HERG) screening is a crucial step in evaluating the potential cardiotoxic effects of a drug or compound. This screening process plays a vital role in preclinical safety assessment within the drug discovery and development phases, serving to guarantee the safety and effectiveness of newly developed therapeutic agents.

HERG screening encompasses two primary categories, gene KCNH2 and mutant KCNH2. The KCNH2 gene, also recognized as the human ether-a-go-go-related gene (hERG) or hERG gene, encodes the alpha subunit of a potassium ion channel pivotal in the regulation of the heart's electrical activity. This gene encompasses diverse ion channels, including both voltage-gated and ligand-gated variations. Its applications span across various therapeutic domains, including antiarrhythmics, antipsychotics, antibiotics, and others, underscoring its critical role in multiple medical contexts.

The HERG screening market research report is one of a series of new reports from The Business Research Company that provides HERG screening market statistics, including HERG screening industry global market size, regional shares, competitors with a HERG screening market share, detailed HERG screening market segments, market trends and opportunities, and any further data you may need to thrive in the HERG screening industry. This HERG screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The HERG screening market size has grown rapidly in recent years. It will grow from $1.42 billion in 2023 to $1.62 billion in 2024 at a compound annual growth rate (CAGR) of 14.2%. The expansion observed in the historical period can be attributed to several contributing factors, including the uptick in drug development activities, heightened regulatory requirements, increased awareness of cardiac safety considerations, and a rising incidence of cardiac disorders.

The HERG screening market size is expected to see rapid growth in the next few years. It will grow to $2.60 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The projected growth in the forecast period can be attributed to the expansion of personalized medicine, a surge in outsourcing of drug development activities, the emergence of new markets and research avenues, and a heightened focus on non-cardiac safety assessments. Key trends anticipated in this period include advancements in in vitro models, the integration of genomic and proteomic data, progress in computational approaches, a specific emphasis on pediatric drug safety, and increased collaborations for data sharing and standardization.

The anticipated increase in the number of patients with heart disorders is set to drive the growth of the HERG screening market. Heart disorders, encompassing various conditions affecting the heart and blood vessels, pose serious health risks and are influenced by factors such as unhealthy lifestyles, an aging population, genetic predispositions, diabetes, and metabolic syndrome. HERG screening plays a crucial role in identifying potential drug candidates, preventing adverse cardiac events, particularly torsade de pointes (TdP), and ultimately improving patient outcomes. As of May 2023, the Centers for Disease Control and Prevention reported that in the US, 1 in 20 adults aged 20 and older had cardiovascular diseases, with 695,000 people suffering from cardiovascular diseases in 2021, resulting in 375,476 deaths. Additionally, in March 2022, the Office for National Statistics reported 19,440 heart attack-related deaths in the UK in 2020, rising to 20,061 in 2021. The increasing prevalence of heart disorders is a pivotal factor driving the growth of the HERG screening market.

Key companies in the HERG screening market are actively focusing on innovative solutions, including GLP-certified HERG screening services, to enhance cardiac safety assessments during drug development processes. GLP-certified HERG screening involves screening the human ether-a-go-go related gene (hERG) using the conventional whole-cell patch-clamp technique, ensuring compliance with regulatory guidelines such as ICH S7A and ICH S7B. These guidelines are critical for safety pharmacology studies in drug development. For example, in August 2023, Metrion Biosciences Ltd., a UK-based pharmaceutical company, introduced the GLP-certified hERG screening service. This service is designed to support small-molecule therapeutic development, complement the existing cardiac safety service portfolio, and employ the conventional whole-cell patch-clamp technique to assess potential cardiac liabilities before entering Phase 1 clinical trials. It provides regulatory guidance for safety pharmacology studies and offers high-quality biology services for ion channel targets.

In September 2021, ApconiX, a UK-based company specializing in fast and efficient HERG screening for drug discovery projects, partnered with PhysioStim to establish a European Center of Excellence for preclinical cardiovascular safety evaluation. The collaboration aims to provide a comprehensive range of preclinical cardiac safety tests, including automated electrophysiology for HERG screening, CiPA ion channel assays, and GLP compliance assays. PhysioStim, a France-based preclinical contract research organization, specializes in cardiac safety and cardiovascular studies.

Major companies operating in the HERG screening market are Eurofins-Cerep SA., Aviva Biosciences Inc., AstraZeneca Public Limited Company, Merck KGaA, Charles River Laboratories Inc., Abcam Public Limited Company, Molecular Devices LLC, Caliper Life Sciences Inc., Crprotex Limited, ChanTest Corporation, Creative bioarray Inc., Cellular Dynamics International Inc., Nanion Technologies, Essen Bioscience, ABR-Affinity BioReagents Inc., ACEA Biosciences Inc., Metrion biosciences Inc., Aurora Biomed Inc., Aureus Sciences, RedShift BioAnalytics, B'SYS GmbH, Cambridge Bioscience Ltd., Sophion Bioscience Inc., Fluxion Biosciences Inc., ChemAxon Ltd.

North America was the largest region in the HERG screening market in 2023. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the herg screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the herg screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The HERG screening market includes revenues earned by entities by providing services such as in vitro HERG assays, patch clamp electrophysiology, data analysis and interpretation, consultation and regulatory support, and customized assay development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

HERG Screening Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on HERG screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for HERG screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The HERG screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Gene KCNH2; Mutant KCNH2
• 2) By Ion Channel: Voltage-Gated; Ligand Gated
• 3) By Applications: Antiarrhythmic; Antipsychotic; Antibiotics; Other Applications
• Companies Mentioned: Eurofins-Cerep SA.; Aviva Biosciences Inc.; AstraZeneca Public Limited Company; Merck KGaA; Charles River Laboratories Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. HERG Screening Market Characteristics

3. HERG Screening Market Trends And Strategies

4. HERG Screening Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global HERG Screening Market Size and Growth

• 5.1. Global HERG Screening Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global HERG Screening Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global HERG Screening Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. HERG Screening Market Segmentation

• 6.1. Global HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Gene KCNH2
• Mutant KCNH2
• 6.2. Global HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Voltage-Gated
• Ligand Gated
• 6.3. Global HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Antiarrhythmic
• Antipsychotic
• Antibiotics
• Other Applications

7. HERG Screening Market Regional And Country Analysis

• 7.1. Global HERG Screening Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global HERG Screening Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific HERG Screening Market

• 8.1. Asia-Pacific HERG Screening Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China HERG Screening Market

• 9.1. China HERG Screening Market Overview
• 9.2. China HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India HERG Screening Market

• 10.1. India HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan HERG Screening Market

• 11.1. Japan HERG Screening Market Overview
• 11.2. Japan HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia HERG Screening Market

• 12.1. Australia HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia HERG Screening Market

• 13.1. Indonesia HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea HERG Screening Market

• 14.1. South Korea HERG Screening Market Overview
• 14.2. South Korea HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe HERG Screening Market

• 15.1. Western Europe HERG Screening Market Overview
• 15.2. Western Europe HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK HERG Screening Market

• 16.1. UK HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany HERG Screening Market

• 17.1. Germany HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France HERG Screening Market

• 18.1. France HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy HERG Screening Market

• 19.1. Italy HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain HERG Screening Market

• 20.1. Spain HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe HERG Screening Market

• 21.1. Eastern Europe HERG Screening Market Overview
• 21.2. Eastern Europe HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia HERG Screening Market

• 22.1. Russia HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America HERG Screening Market

• 23.1. North America HERG Screening Market Overview
• 23.2. North America HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA HERG Screening Market

• 24.1. USA HERG Screening Market Overview
• 24.2. USA HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada HERG Screening Market

• 25.1. Canada HERG Screening Market Overview
• 25.2. Canada HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America HERG Screening Market

• 26.1. South America HERG Screening Market Overview
• 26.2. South America HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil HERG Screening Market

• 27.1. Brazil HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East HERG Screening Market

• 28.1. Middle East HERG Screening Market Overview
• 28.2. Middle East HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa HERG Screening Market

• 29.1. Africa HERG Screening Market Overview
• 29.2. Africa HERG Screening Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. HERG Screening Market Competitive Landscape And Company Profiles

• 30.1. HERG Screening Market Competitive Landscape
• 30.2. HERG Screening Market Company Profiles
  • 30.2.1. Eurofins-Cerep SA.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Aviva Biosciences Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. AstraZeneca Public Limited Company
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Merck KGaA
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Charles River Laboratories Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. HERG Screening Market Other Major And Innovative Companies

• 31.1. Abcam Public Limited Company
• 31.2. Molecular Devices LLC
• 31.3. Caliper Life Sciences Inc.
• 31.4. Crprotex Limited
• 31.5. ChanTest Corporation
• 31.6. Creative bioarray Inc.
• 31.7. Cellular Dynamics International Inc.
• 31.8. Nanion Technologies
• 31.9. Essen Bioscience
• 31.10. ABR-Affinity BioReagents Inc.
• 31.11. ACEA Biosciences Inc.
• 31.12. Metrion biosciences Inc.
• 31.13. Aurora Biomed Inc.
• 31.14. Aureus Sciences
• 31.15. RedShift BioAnalytics

32. Global HERG Screening Market Competitive Benchmarking

33. Global HERG Screening Market Competitive Dashboard

34. Key Mergers And Acquisitions In The HERG Screening Market

35. HERG Screening Market Future Outlook and Potential Analysis

• 35.1 HERG Screening Market In 2028 - Countries Offering Most New Opportunities
• 35.2 HERG Screening Market In 2028 - Segments Offering Most New Opportunities
• 35.3 HERG Screening Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer